tazobactam has been researched along with Dermatoses in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gesser, RM; McCarroll, KA; Woods, GL | 1 |
| Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M | 1 |
| File, TM; Tan, JS | 1 |
| Liu, Y; Wang, R; Yu, B | 1 |
| Ceesay, TP; Gesser, R; Graham, DR; Holtom, P; Lucasti, C; Malafaia, O; McAdams, A; Nichols, RL; Perez, NQ; Woods, GL | 1 |
1 review(s) available for tazobactam and Dermatoses
| Article | Year |
|---|---|
Treatment of skin and soft-tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Fasciitis; Humans; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases; Soft Tissue Infections; Surgical Wound Infection; Tazobactam | 1995 |
3 trial(s) available for tazobactam and Dermatoses
| Article | Year |
|---|---|
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Infusions, Intravenous; Lactams; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Skin Diseases; Statistics, Nonparametric; Tazobactam; Treatment Outcome | 2004 |
[Multicentre clinical trial on efficacy and safety of domestic piperacillin/tazobactam for treatment of acute bacterial infections].
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Drug Therapy, Combination; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases; Tazobactam; Treatment Outcome | 2001 |
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Skin Diseases; Staphylococcus aureus; Tazobactam; Treatment Outcome | 2002 |
1 other study(ies) available for tazobactam and Dermatoses
| Article | Year |
|---|---|
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome | 2005 |